Project Grant R01DK141536
Award Date 9/5/25
Completion Date 6/30/30
Dollars Obligated $756K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This $192,215 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support a research project titled "Assessing Patient-Centric Factors and Enhancing Risk Communication to Improve Treatment Persistence in Kidney and Cardiovascular Care" at the University of California, San Francisco (UCSF). The project aims to develop an effective risk communication aid to...
- This federal Project Grant award of $779,978 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to identify optimal supportive components and adaptive treatment sequences for improving diabetes outcomes and addressing unmet social needs among individuals with high HbA1c levels. The overarching goal is to conduct a 12-month Sequential Multiple Assignment Randomized Trial (SMART) to evaluate...
- This Project Grant award of $714,440 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a research study to advance precision diabetes medicine. The key objectives are to: Define subphenotypes of prediabetes and early type 2 diabetes based on underlying metabolic physiology, including insulin resistance, beta-cell function, incretin effect, and hepatic insulin resistance. Evaluate...
- This $161,664 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop "DREAM: BUILDING EQUITABLE PREDICTIVE MODELS FOR PERSONALIZED DIABETES PHARMACOTHERAPY." The project has three key objectives: (1) creating predictive models to estimate individualized outcomes like HbA1c, weight, and hypoglycemia for diabetes medication options,...
- This Cooperative Agreement award of $2,367,892 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to develop and evaluate a novel approach to mitigate the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) and chronic kidney disease (CKD) who are taking sodium-glucose cotransporter (SGLT) inhibitor medications. The project aims...
- This $802,363 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a research study at Emory University from September 2025 to June 2030 to develop models for predicting the benefits of GLP-1 receptor agonist (GLP-1RA) treatments in preventing obesity-related cardiometabolic diseases. The study aims to use clinical...
- This $1,089,491 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to develop novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories relevant to disease onset and progression for large, diverse healthcare datasets like electronic medical records and biobanks. The research, to be conducted by the University of...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will evaluate an Adaptive Dietary Intervention (ADI) leveraging Continuous Glucose Monitoring (CGM) for Asian Americans with Type 2 Diabetes (T2D). The $970,016 grant, awarded on September 19, 2025, will be used by New York University (NYU) to examine the feasibility, acceptability, and effects of...
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...